(1)
Celesia, B. M.; Marino, A.; Fontana del Vecchio, R.; Bruno, R.; Palermo, F.; Gussio, M.; Nunnari, G.; Cacopardo, B. IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS µL?. Mediterr J Hematol Infect Dis 2019, 11, e2019063.